日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification.

蛋白磷酸酶甲基酯酶 1 在诊断、预后和免疫调节中的价值：从泛癌分析到乳腺癌验证。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1770711
Wang Yiyang, Zhang Yue, Li Yongxiang, Ma Haotian, Zhao Jiawei, Ismtula Dilimulati, Guo Chenming
乳腺癌
免疫/内分泌
发表日期：2026
文献求助 收藏

Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker.

综合泛癌分析和乳腺癌验证确定 BEND3 为潜在的预后和免疫生物标志物。

期刊:Breast Cancer-Targets and Therapy
影响因子:3.4
doi:10.2147/BCTT.S553681
Gou Yuting, Li Yongxiang, Wang Yiyang, Ma Haotian, Li Haocong, Geni Reyima, Ismtula Dilimulati, Guo Chenming
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer.

Bystin 是一种预后和免疫生物标志物：从泛癌分析到乳腺癌验证

期刊:Breast Cancer-Targets and Therapy
影响因子:3.4
doi:10.2147/BCTT.S537429
Aimaiti Xiyidan, Wang Yiyang, Ismtula Dilimulati, Li Yongxiang, Ma Haotian, Wang Junyi, Elihamu Dilraba, Guo Chenming
免疫/内分泌
乳腺癌
发表日期：2025
文献求助 收藏

CLIC6's role in cancer: from broad analysis to breast cancer validation

CLIC6在癌症中的作用：从广泛分析到乳腺癌验证

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1667589
Wang, Junyi; Wang, Yiyang; Ma, Haotian; Li, Yongxiang; Hou, Jiayue; Li, Jiaqi; Ismtula, Dilimulati; Guo, Chenming
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation

CORO1A：一种基于乳腺癌验证的泛癌预后、诊断和免疫生物标志物

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1670526
Elihamu, Dilraba; Li, Yongxiang; Wang, Yiyang; Cui, Haiyan; Xing, Yiting; Peng, Haohao; Ismtula, Dilimulati; Guo, Chenming
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer

结合乳腺癌的实验验证，微管蛋白α-1b链被确定为泛癌症的预后和免疫生物标志物

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-024-58982-z
Yiyang Wang #, Yongxiang Li #, Yubo Jing, Yuqi Yang, Haiyan Wang, Dilimulati Ismtula, Chenming Guo
免疫
乳腺癌
发表日期：2024
文献求助 收藏

Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers

凝溶胶蛋白：对潜在预后、诊断和免疫生物标志物的全面泛癌症分析

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2023.1093163
Yiyang Wang, Xiaojuan Bi, Zhiwen Luo, Haiyan Wang, Dilimulati Ismtula, Chenming Guo
免疫
发表日期：2023
文献求助 收藏

Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer

细胞因子诱导的细胞凋亡抑制剂1：浸润性乳腺癌潜在诊断、预后和免疫生物标志物的综合分析

期刊:Translational Cancer Research
影响因子:1.7
doi:10.21037/tcr-23-34
Luo, Zhiwen; Wang, Yiyang; Bi, Xiaojuan; Ismtula, Dilimulati; Wang, Haiyan; Guo, Chenming
乳腺癌
表观遗传
免疫/内分泌
肿瘤
凋亡
细胞生物学
肿瘤免疫
发表日期：2023
文献求助 收藏

TIGIT as a Novel Prognostic Marker for Immune Infiltration in Invasive Breast Cancer

TIGIT 作为浸润性乳腺癌免疫浸润的新型预后标志物

期刊:Combinatorial Chemistry & High Throughput Screening
影响因子:1.6
doi:10.2174/1386207325666220629162823
Chenming Guo, Zhiwen Luo, Dilimulati Ismtula, Xiaojuan Bi, Han Kong, Yiyang Wang, Zhen Yang, Xinmin Mao
肿瘤
乳腺癌
发表日期：2023
文献求助 收藏